Polaris Group (TPE:6550)

Market Cap	34.08B
Revenue (ttm)	107.00M
Net Income (ttm)	-2.50B
Shares Out	770.25M
EPS (ttm)	-3.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,362,088
Average Volume	1,663,218
Open	42.20
Previous Close	41.50
Day's Range	42.20 - 44.45
52-Week Range	26.35 - 76.50
Beta	0.13
RSI	62.39
Earnings Date	May 9, 2025

About Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications. It also provides healthcare consulting, staffing, and MDS solutions. The company was founded in 1988 and is based in Tampa, Florida.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 165
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6550

Financial Performance

In 2024, Polaris Group's revenue was 107.00 million, an increase of 1330.29% compared to the previous year's 7.48 million. Losses were -2.50 billion, 67.7% more than in 2023.